Hemogenyx Pharmaceuticals (HEMO.L): CAR-T cells are effective Against AML in vivo
20 Feb 2020
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions
HemoGenyx Pharmaceuticals Plc (HEMO:LON) | 1.6 0 (-3.1%) | Mkt Cap: 22.0m
- Published:
20 Feb 2020 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
3
Hemogenyx Pharmaceuticals (HEMO.L): CAR-T cells are effective Against AML in vivo